Acute myeloid leukemia (AML) is a cancer of immature blood cells. When the early myeloid cell matures normally, it will become either a mature white blood cell, red blood cell, or platelet.
Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells ...
Focused on the evaluation of strategic alternativesAdopted a restructuring plan to extend capital resources, incurring a reduction in workforce ...
Science Featured on MSN29d
This Common Cancer Treatment Might Help Patients Stay Healthier for LongerUnderstanding how to keep leukemia in remission for longer in older patients remains a significant challenge in cancer ...
Early clearance of measurable residual disease (MRD) after induction therapy in patients with acute myeloid leukemia (AML) is associated with significantly better relapse-free survival (RFS ...
The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...
The journey of fighting Acute Myeloid Leukemia (AML) in India encompasses severe physical and emotional challenges for both patients and caregivers. Integrating mental health support into cancer ...
The trial is being conducted as part of the Leukemia & Lymphoma Society's Beat AML Master Clinical Trial. ASH Annual Meeting. The trial is now enrolling a cohort of newly diagnosed patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback